Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 Including: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs. Covering: Novartis AG, Sanofi S.A., Pfizer Inc. and Gilead Sciences Inc.
July 2018
430
About the Report
About the Report
The global pharmaceutical drug market was worth USD 934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth USD 1,170.4 billion by 2021. Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma market does not register in the percentage figures. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.
North America accounted for 36.5% of the global pharmaceutical drugs market in 2017 and was worth USD 341.1 billion. This market share was primarily due to the better healthcare system, access to high value drugs, healthcare awareness, high per capita expenditure on healthcare and high GDP of the region. Asia Pacific was the second largest region with a share of 21.8% in 2017 and the market was worth USD 200.8 billion. This was mainly due to the prevalence of chronic conditions and the large population based of the region. Western Europe was the third largest region accounting for USD 180.9 billion or 19.4% of the market. This market was driven by increased investment in research and development, aging population, ability to afford high value drugs and established healthcare system. South America was the fourth largest region accounting for USD 80.9 billion or 8.6% of the market. Rising disposable income, government healthcare policies and availability of affordable generic drugs are main drivers of this market. Eastern Europe was fifth largest region accounting for USD 60.9 billion or 6.5% of the market followed by Middle East with a share of 4.4%, USD 41.3 billion, and Africa with a market worth USD 28.8 billion in 2017.
At the country level, The USA was the largest country in the pharmaceutical drugs market in 2017, accounting for USD 234.7 billion or 25.1% market. The USA's per capita medical drugs spend has been and will be to 2021 the world's highest, followed by those of Australia and Germany. China was the second largest country accounting for USD 52.6 billion followed by Japan with a market worth USD 43 billion in 2017. Germany was the fourth largest country accounting for USD 37 billion in 2017. Russia was the smallest country accounting for USD 12.1 billion and this can be attributed to the presence of generics and less reliance on imported pharmaceutical drugs.
As a percentage of GDP in 2013 the USA's drugs expenditure was highest, but by 2017 it had been overtaken by both Brazil and Italy, whose market was worth USD 29.1 billion and USD 24.7 billion respectively, and the situation will continue to 2021. In terms of the number of pharmacist, the huge populations of India and China meant that these countries had the highest number of pharmacists in 2017. Three of the BRICs, India, China and Brazil, have low spend on pharma, despite very high numbers of pharmacists, implying that the drugs revenue per pharmacist in these countries is relatively low. With more generic drugs occupying the market, it was observed that 70% of drug sales in India were generics whereas in many Western countries it was much lower, for example in Italy generics made up only 11% of the market. New drug approvals in 2017 were highest in Brazil, 61, and lowest in the USA, followed by Europe. In part this pattern is explained by countries approving drugs approved in the USA in earlier years and the slow and difficult process for new drug approvals in the USA and Europe.
At the global level, pharmaceutical drugs are segmented based on the therapeutic area with drugs for musculoskeletal disorders as the largest segment worth USD 130.2 billion in 2017. Cardiovascular drugs were the second largest segment followed by oncology drugs with a market worth USD 129.6 billion and 125.9 billion respectively. Ophthalmology Drugs was the smallest major segment in the pharmaceutical drugs market worth about USD 27.7 billion.
Products
Products
Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs
Companies
North America: Pfizer Inc., Amgen, AbbVie, Abbott Laboratories, F. Hoffmann-La Roche, Gilead Science, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Astellas Pharma, Q Pharm, 3M Pharmaceuticals
Asia-Pacific: Shanghai Pharmaceuticals, Shanghai Fosun Pharmaceutical, Cipla, Dr. Reddy's Laboratories Ltd., Sun Pharma, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo
Western Europe: Bayer, Roche, Novartis, Sanofi, GlaxoSmithKline, Teva Pharmaceutical Industries, AstraZeneca, Boehringer Ingelheim, Novo Nordisk
South America: EMS Pharma, Hypermarcas, Medley, Sanofi, Novartis, Ache, Eurofarma, Takeda, Bayer, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Libbs, Uniao Quimica, Roche, Merck, Pfizer, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline
Eatern Europe: Pharmstandard, STADA CIS Russian Holding, Sotex, Microgen, AKRIKHIN, Sanofi, Aventis, Novartis, Roche, Bayer, Pfizer, GlaxoSmithKline
Middle East: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), Gulf Pharmaceutical Industries (Julphar), Pfizer, Merck, GSK, Abbott Laboratories
Africa: Sanofi, Novartis, Cipla, Pfizer, Roche, Bayer, Adcock Ingram, Johnson & Johnson, Aspen
Table of Contents
Table of Contents
1. Executive Summary
2. Pharmaceutical Drugs Market Characteristics
2.1. Global Pharmaceutical Drugs Market Size And Growth
2.2. Global Pharmaceutical Drugs Historic Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
2.3. Global Pharmaceutical Drugs Market Forecast Growth
2.3.1. Drivers Of The Market
2.3.2. Restraints On The Market
4. Global Pharmaceutical Drugs Market, PESTLE Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental
5. Pharmaceutical Drugs Market Customer Information
6. Pharmaceutical Drugs Market Regional And Country Analysis
6.1. Pharmaceutical Drugs Market, 2017, Split By Region
6.2. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region
6.3. Pharmaceutical Drugs Market, 2017, Split By Country
6.4. Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Country
7. Global Pharmaceutical Drugs Market Segmentation
7.1. Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion
7.1.1. Musculoskeletal Disorders Drugs
7.1.2. Cardiovascular Drugs
7.1.3. Oncology Drugs
7.1.4. Anti-infective Drugs
7.1.5. Metabolic Disorder Drugs
7.1.6. Central Nervous System Drugs
7.1.7. Genito-urinary Drugs
7.1.8. Respiratory Drugs
7.1.9. Gastrointestinal Drugs
7.1.10. Hematology Drugs
7.1.11. Dermatology Drugs
7.1.12. Ophthalmology Drugs
7.2. Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segments
8. Pharmaceutical Drugs Market Segments And Subsegments
8.1. Musculoskeletal Disorders Drugs
8.1.1. Musculoskeletal Disorders Drugs Market Characteristics
8.1.2. Musculoskeletal Disorders Drugs Market Trends & Strategies
8.1.3. Global Musculoskeletal Disorders Drugs Market, By Subsegment
8.1.3.1. Drugs for Rheumatoid Arthritis
8.1.3.2. Muscle Relaxants
8.1.3.3. Others
8.1.4. Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.1.5. Global Musculoskeletal Drugs Market Competitive Landscape
8.1.6. Global Musculoskeletal Drugs Market Key Mergers And Acquisitions
8.2. Cardiovascular Drugs
8.2.1. Cardiovascular Drugs Market Characteristics
8.2.2. Cardiovascular Drugs Market Trends & Strategies
8.2.3. Global Cardiovascular Drugs Market, Segmentation By Subsegment
8.2.3.1. Anti-hypertensive Drugs
8.2.3.2. Hypolipidemics
8.2.3.3. Anti Thrombotics
8.2.3.4. Other Drugs For Cardiovascular Diseases
8.2.4. Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.2.5. Global Cardiovascular Drugs Market Competitive Landscape
8.2.6. Global Cardiovascular Drugs Market Key Mergers And Acquisitions
8.3. Oncology Drugs
8.3.1. Oncology Drugs Market Characteristics
8.3.2. Oncology Drugs Market Trends & Strategies
8.3.3. Global Oncology Drugs Market, Segmentation By Subsegment
8.3.3.1. Blood Cancer
8.3.3.2. Breast Cancer
8.3.3.3. Cervical Cancer
8.3.3.4. Lung Cancer
8.3.3.5. Colorectal Cancer
8.3.3.6. Non-Small Cell Lung Cancer
8.3.3.7. Prostate Cancer
8.3.3.8. Kidney Cancer
8.3.3.9. Gastric Cancer
8.3.3.10. Brain Tumor
8.3.3.11. Pancreatic Cancer
8.3.3.12. Skin Cancer
8.3.3.13. Ovarian Cancer
8.3.3.14. Bladder Cancer
8.3.3.15. Thyroid Cancer
8.3.3.16. Others
8.3.4. Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.3.5. Global Oncology Drugs Market Competitive Landscape
8.3.6. Global Oncology Drugs Market Key Mergers And Acquisitions
8.4. Anti-Infective Drugs
8.4.1. Anti-infective Drugs Market Characteristics
8.4.2. Anti-infective Drugs Market Trends & Strategies
8.4.3. Global Anti-Infective Drugs Market, Segmentation By Subsegment
8.4.3.1. Antivirals
8.4.3.2. Antibiotics
8.4.3.3. Antifungals
8.4.3.4. Antiparasitic
8.4.4. Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rates, By Subsegment
8.4.5. Global Anti-Infective Drugs Market Competitive Landscape
8.4.6. Global Anti-Infective Drug Market Key Mergers and Acquisitions
8.5. Metabolic Disorders Drugs
8.5.1. Metabolic Disorders Drugs Market Characteristics
8.5.2. Metabolic Disorders Drugs Market Trends & Strategies
8.5.3. Global Metabolic Disorders Drugs Market, Segmentation By Subsegment
8.5.3.1. Anti-diabetics Drugs
8.5.3.2. Anti-thyroid drugs
8.5.3.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
8.5.4. Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.5.5. Global Metabolic Disorder Drugs Market Competitive Landscape
8.5.6. Global Metabolic Disorders Drugs Market Key Mergers And Acquisitions
8.6. Central Nervous System Drugs
8.6.1. Central Nervous System Drugs Market Characteristics
8.6.2. Central Nervous System Drugs Market Trends & Strategies
8.6.3. Global Central Nervous System Drugs Market, Segmentation By Subsegment
8.6.3.1. Anesthetics
8.6.3.2. Analgesics
8.6.3.3. Anti-Parkinson drugs
8.6.3.4. Anti-Epileptics
8.6.3.5. Other CNS drugs
8.6.4. Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.6.5. Global Central Nervous System Market Competitive Landscape
8.6.6. Global Central Nervous System Drugs Market Key Mergers And Acquisitions
8.7. Genito-Urinary Drugs
8.7.1. Genito-Urinary Drugs Market Characteristics
8.7.2. Genito-Urinary Drugs Market Trends & Strategies
8.7.3. Global Genito-Urinary Drugs Market, Segmentation By Subsegment
8.7.3.1. Hormonal Contraceptives
8.7.3.2. Drugs For Hormonal Replacement Therapy
8.7.3.3. Drugs For Infections And Others
8.7.3.4. Drugs for Benign prostatic hypertrophy
8.7.3.5. Drugs For Erectile Dysfunction
8.7.3.6. Drugs For Urinary Incontinence And Overactive Bladder
8.7.3.7. Drugs for Infertility
8.7.3.8. Diuretics
8.7.4. Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment
8.7.5. Global Genito-Urinary Drugs Market Competitive Landscape
8.7.6. Genito-urinary Drugs Market Key Mergers And Acquisitions
8.8. Respiratory Diseases
8.8.1. Respiratory Diseases Drugs Market Characteristics
8.8.2. Respiratory Diseases Drugs Market Trends & Strategies
8.8.3. Global Respiratory Diseases Market, Segmentation By Subsegment
8.8.3.1. Anti-Asthmatics And COPD Drugs
8.8.3.2. Cough And Cold Preparations
8.8.4. Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.8.5. Global Respiratory Diseases Drugs Market Competitive Landscape
8.8.6. Global Respiratory Drugs Market Key Mergers And Acquisitions
8.9. Gastrointestinal Drugs
8.9.1. Gastrointestinal Drugs Market Characteristics
8.9.2. Gastrointestinal Drugs Market Trends & Strategies
8.9.3. Global Gastrointestinal Drugs Market, Segmentation By Subsegment
8.9.3.1. Antiulcerants
8.9.3.2. Vitamins And Minerals
8.9.3.3. Antacids
8.9.3.4. Antiemetics And Antinauseants
8.9.3.5. Antiobesity
8.9.3.6. Antidiarrhoeals
8.9.4. Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.9.5. Global Gastrointestinal Drugs Market Competitive Landscape
8.9.6. Global Gastrointestinal Drugs Market Key Mergers And Acquisitions
8.1. Hematology Drugs
8.10.1. Hematology Drugs Market Characteristics
8.10.2. Hematology Drugs Market Trends & Strategies
8.10.3. Global Hematology Drugs Market, Segmentation By Subsegment
8.10.3.1. Blood Products
8.10.3.2. Anemia And Other Blood Disorder Drugs
8.10.4. Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.10.5. Global Hematology Drugs Market Competitive Landscape
8.10.6. Global Hematology Drugs Market Key Mergers And Acquisitions
8.11. Dermatology Drugs
8.11.1. Dermatology Drugs Market Characteristics
8.11.2. Dermatology Drugs Market Trends & Strategies
8.11.3. Global Dermatology Drugs Market Competitive Landscape
8.11.4. Dermatology Drugs Market Key Mergers And Acquisitions
8.12. Ophthalmology Drugs
8.12.1. Ophthalmology Drugs Market Characteristics
8.12.2. Ophthalmology Drugs Market Trends & Strategies
8.12.3. Global Ophthalmology Drugs Market, Segmentation By Subsegment
8.12.3.1. Antiglaucoma
8.12.3.2. Dry Eye Medication
8.12.3.3. Other Opthalmological Drugs
8.12.4. Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment
8.12.5. Global Ophthalmology Drugs Market Competitive Landscape
8.12.6. Ophthalmology Drugs Market Key Mergers And Acquisitions
9. Pharmaceutical Drugs Market Comparison With Macro Economic Factors
9.1. Pharmaceutical Drugs Market Size And Percentage Of GDP, Global
9.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
9.3. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
9.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
9.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
10. Pharmaceutical Drugs Market Comparison With Industry Metrics
10.1. Number Of General Practitioners 2017, By Country
10.2. Average Pharmaceutical Drugs Revenue Per General Practitioner, 2017, By Country
10.3. Number Of Pharmacists, 2017, By Country
10.4. Average Pharmaceutical Drugs Revenue Per Pharmacist, 2017, By Country
10.5. Number Of Employees In Pharmaceutical Industry, 2017, By Country
10.6. Average Revenue Per Pharmaceutical Employee, 2017, By Country
10.7. Number Of Pharmaceutical Enterprises, 2017, By Country
10.8. Average Pharmaceutical Drugs Revenue Per Pharmaceutical Enterprise, 2017, By Country
10.9. Number Of Pharmacies Per 100,000 Population, 2017, By Country
10.1. Generic & Branded Sales Proportion By Country (Value), 2016, By Country
10.11. New Drug Approvals, 2017, By Country
11. Asia-Pacific Pharmaceutical Drugs Market
11.1. Asia-Pacific Pharmaceutical Drugs Market Overview
11.2. Asia Pacific Pharmaceutical Market
11.3. Asia Pacific Pharmaceutical Drugs Historic Market Growth
11.4. Asia Pacific Pharmaceutical Drugs Market Forecast Growth
11.5. Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type
11.6. Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12. Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
12.1. China Pharmaceutical Drugs Market
12.1.1. China Pharmaceutical Drugs Market Overview
12.1.2. China Pharmaceutical Market
12.1.3. China Pharmaceutical Drugs Historic Market Growth
12.1.4. China Pharmaceutical Drugs Market Forecast Growth
12.1.5. China Pharmaceutical Drugs Market, Segmentation By Type
12.1.6. China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.2. India Pharmaceutical Drugs Market
12.2.1. India Pharmaceutical Drugs Market Overview
12.2.2. India Pharmaceutical Market
12.2.3. India Pharmaceutical Drugs Historic Market Growth
12.2.4. India Pharmaceutical Drugs Market Forecast Growth
12.2.5. India Pharmaceutical Drugs Market, Segmentation By Type
12.2.6. India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.3. Japan Pharmaceutical Drugs Market
12.3.1. Japan Pharmaceutical Drugs Market Overview
12.3.2. Japan Pharmaceutical Market
12.3.3. Japan Pharmaceutical Drugs Historic Market Growth
12.3.4. Japan Pharmaceutical Drugs Market Forecast Growth
12.3.5. Japan Pharmaceutical Drugs Market, Segmentation By Type
12.3.6. Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
12.3. Australia Pharmaceutical Drugs Market
12.3.1. Australia Pharmaceutical Market
12.3.2. Australia Pharmaceutical Drugs Historic Market Growth
12.3.3. Australia Pharmaceutical Drugs Market Forecast Growth
12.3.4. Australia Pharmaceutical Drugs Market, Segmentation By Type
12.3.5. Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
13. Western Europe Pharmaceutical Drugs Market
13.1. Western Europe Pharmaceutical Drugs Market Overview
13.2. Western Europe Pharmaceutical Market
13.3. Western Europe Pharmaceutical Drugs Historic Market Growth
13.4. Western Europe Pharmaceutical Drugs Market Forecast Growth
13.5. Western Europe Pharmaceutical Drugs Market, Segmentation By Type
13.6. Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14. Western Europe Pharmaceutical Drugs Market: Country Analysis
14.1. UK Pharmaceutical Drugs Market
14.1.1. UK Pharmaceutical Drugs Market Overview
14.1.2. UK Pharmaceutical Market
14.1.3. UK Pharmaceutical Drugs Historic Market Growth
14.1.4. UK Pharmaceutical Drugs Market Forecast Growth
14.1.5. UK Pharmaceutical Drugs Market, Segmentation By Type
14.1.6. UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.2. Germany Pharmaceutical Drugs Market
14.2.1. Germany Pharmaceutical Market
14.2.2. Germany Pharmaceutical Drugs Historic Market Growth
14.2.3. Germany Pharmaceutical Drugs Market Forecast Growth
14.2.4. Germany Pharmaceutical Drugs Market, Segmentation By Type
14.2.5. Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.3. France Pharmaceutical Drugs Market
14.3.1. France Pharmaceutical Market
14.3.2. France Pharmaceutical Drugs Market Historic Growth
14.3.3. France Pharmaceutical Drugs Market Forecast Growth
14.3.4. France Pharmaceutical Drugs Market, Segmentation By Type
14.3.5. France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.4. Italy Pharmaceutical Drugs Market
14.4.1. Italy Pharmaceutical Market
14.4.2. Italy Pharmaceutical Drugs Historic Market Growth
14.4.3. Italy Pharmaceutical Drugs Market Forecast Growth
14.4.4. Italy Pharmaceutical Drugs Market, Segmentation By Type
14.4.5. Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
14.5. Spain Pharmaceutical Drugs Market
14.5.1. Spain Pharmaceutical Market
14.5.2. Spain Pharmaceutical Drugs Historic Market Growth
14.5.3. Spain Pharmaceutical Drugs Market Forecast Growth
14.5.4. Spain Pharmaceutical Drugs Market, Segmentation By Type
14.5.5. Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
15. Eastern Europe Pharmaceutical Drugs Market
15.1. Eastern Europe Pharmaceutical Drugs Market Overview
15.2. Eastern Europe Pharmaceutical Market
15.3. Eastern Europe Pharmaceutical Drugs Historic Market Growth
15.4. Eastern Europe Pharmaceutical Drugs Market Forecast Growth
15.5. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type
15.6. Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type
15.7. Eastern Europe Pharmaceutical Drugs Market: Country Analysis
15.7.1. Russia Pharmaceutical Drugs Market
15.7.2. Russia Pharmaceutical Drugs Historic Market Growth
15.7.3. Russia Pharmaceutical Drugs Market Forecast Growth
15.7.4. Russia Pharmaceutical Drugs Market, Segmentation By Type
15.7.5. Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
16. North America Pharmaceutical Drugs Market
16.1. North America Pharmaceutical Drugs Market Overview
16.2. North America Pharmaceutical Market
16.3. North America Pharmaceutical Drugs Historic Market Growth
16.4. North America Pharmaceutical Drugs Market Forecast Growth
16.5. North America Pharmaceutical Drugs Market, Segmentation By Type
16.6. North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
16.7. North America Pharmaceutical Drugs Market: Country Analysis
16.7.1. USA Pharmaceutical Drugs Market Overview
16.7.2. USA Pharmaceutical Market
16.7.3. USA Pharmaceutical Drugs Historic Market Growth
16.7.4. USA Pharmaceutical Drugs Market Forecast Growth
16.7.5. USA Pharmaceutical Drugs Market, Segmentation By Type
16.7.6. USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
17. South America Pharmaceutical Drugs Market
17.1. South America Pharmaceutical Drugs Market Overview
17.2. South America Pharmaceutical Market
17.3. South America Pharmaceutical Drugs Historic Market Growth
17.4. South America Pharmaceutical Drugs Market Forecast Growth
17.5. South America Pharmaceutical Drugs Market, Segmentation By Type
17.6. South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
17.7. South America Pharmaceutical Drugs Market: Country Analysis
17.7.1. Brazil Pharmaceutical Drugs Market
17.7.2. Brazil Pharmaceutical Market
17.7.3. Brazil Pharmaceutical Drugs Historic Market Growth
17.7.4. Brazil Pharmaceutical Drugs Market Forecast Growth
17.7.5. Brazil Pharmaceutical Drugs Market, Segmentation By Type
17.7.6. Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
18. Middle East Pharmaceutical Drugs Market
18.1. Middle East Pharmaceutical Drugs Market Overview
18.2. Middle East Pharmaceutical Market
18.3. Middle East Pharmaceutical Drugs Historic Market Growth
18.4. Middle East Pharmaceutical Drugs Market Forecast Growth
18.5. Middle East Pharmaceutical Drugs Market, Segmentation By Type
18.6. Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
19. Africa Pharmaceutical Drugs Market
19.1. Africa Pharmaceutical Drugs Market Overview
19.2. Africa Pharmaceutical Market
19.3. Africa Pharmaceutical Drugs Historic Market Growth
19.4. Africa Pharmaceutical Drugs Market Forecast Growth
19.5. Africa Pharmaceutical Drugs Market, Segmentation By Type
19.6. Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type
20. Global Pharmaceutical Drugs Market Competitive Landscape
20.1. Novartis AG
20.1.1. Company Overview
20.1.2. Products And Services
20.1.3. Strategy
20.1.4. Novartis AG Financial Performance
20.2. Sanofi
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Strategy
20.2.4. Sanofi S.A Financial Performance
20.3. Pfizer Inc.
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Strategy
20.3.4. Pfizer Inc. Financial Performance
20.4. Gilead Sciences Inc.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Strategy
20.4.4. Gilead Sciences Inc. Financial Performance
21. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
22. Pharmaceutical Drugs Market Trends And Strategies
23. Market Background: Healthcare Market
23.1. Healthcare Market Characteristics
23.2. Global Healthcare Historic Market Growth
23.2.1. Drivers Of The Market
23.2.2. Restraints On The Market
23.3. Global Healthcare Forecast Market Growth
23.3.1. Drivers Of The Market
23.3.2. Restraints On The Market
23.4. Healthcare Market Geography Regional And Country Analysis
23.4.1. Healthcare Market, 2017, By Region
23.4.2. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region
23.4.3. Healthcare Market, 2017, By Country
23.4.4. Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country
23.5. Healthcare Market Segmentation, By Region, 2017
23.6. Healthcare Market Segmentation, By Country, 2017
23.7. Global Healthcare Market Comparison With Macro Economic Factors
23.7.1. Global Healthcare Market Size, Percentage Of GDP
23.7.2. Global Per Capita Average Healthcare Expenditure
23.7.3. Healthcare Market Comparison With Macro Economic Factors Across Countries
23.7.3.1. Healthcare Market Size, Percentage Of GDP, By Country
23.7.3.2. Per Capita Average Healthcare Expenditure, By Country
23.8. Key Mergers And Acquisitions In The Healthcare Market
23.9. Healthcare Market Trends And Strategies
30. Appendix
List of Figure
Figure 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 31
Figure 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 35
Figure 3: Global Pharmaceutical Drugs Market, PESTLE Analysis 38
Figure 4: Pharmaceutical Drugs Market, 2017, Split By Region 43
Figure 5: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45
Figure 6: Pharmaceutical Drugs Market, 2017, Split By Country 46
Figure 7: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49
Figure 8: Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion 51
Figure 9: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segment 55
Figure 10: Global Musculoskeletal Disorders Drugs Market, Segmentation By Subsegment 61
Figure 11: Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62
Figure 12: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 64
Figure 13: Global Cardiovascular Drugs Market, Segmentation By Subsegment 72
Figure 14: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73
Figure 15: Global Cardiovascular Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 75
Figure 16: Global Oncology Drugs Market, Segmentation By Subsegment 82
Figure 17: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85
Figure 18: Global Oncology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 87
Figure 19: Global Anti-Infective Drugs Market, Segmentation By Subsegment 95
Figure 20: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97
Figure 21: Global Anti-Infective Drugs Market, Key Competitor Market Shares, 2017, Percentages (%) 99
Figure 22: Global Metabolic Disorders Drugs Market, Segmentation By Subsegment 107
Figure 23: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108
Figure 24: Global Metabolic Disorder Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 110
Figure 25: Global Central Nervous System Drugs Market, Segmentation By Subsegment 117
Figure 26: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119
Figure 27: Global Central Nervous System Market, Key Competitor Market Shares, 2017, Percentage (%) 121
Figure 28: Global Genito-Urinary Drugs Market, Segmentation By Subsegment 129
Figure 29: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 131
Figure 30: Global Genito-Urinary Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 133
Figure 31: Global Respiratory Diseases Market, Segmentation By Subsegment 142
Figure 32: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 143
Figure 33: Global Respiratory Diseases Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 144
Figure 34: Global Gastrointestinal Drugs Market, Segmentation By Subsegment 151
Figure 35: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 153
Figure 36: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 155
Figure 37: Global Hematology Drugs Market, Segmentation By Subsegment 163
Figure 38: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164
Figure 39: Global Hematology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 165
Figure 40: Global Dermatology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 173
Figure 41: Global Ophthalmology Drugs Market, Segmentation By Subsegment 181
Figure 42: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183
Figure 43: Global Ophthalmology Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 184
Figure 44: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189
Figure 45: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190
Figure 46: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country 191
Figure 47: Per Capita Average Pharmaceutical Drugs Expenditure, By Country 192
Figure 48: Number Of General Practitioners 2017, By Country, Thousands 194
Figure 49: Average Revenue Per General Practitioner, 2017, By Country, USD Thousands 196
Figure 50: Number Of Pharmacies Per 100,000 Population, 2017, By Country 197
Figure 51: Number Of Pharmacists, 2017, By Country, Thousands 198
Figure 52: Average Revenue Per Pharmacist, 2017, By Country, USD Thousands 199
Figure 53: Number Of Employees In Pharmaceutical Industry, 2017, By Country, Thousands 200
Figure 54: Average Revenue Per Pharmaceutical Employee, 2017, By Country, USD Thousands 202
Figure 55: Number Of Pharmaceutical Enterprises, 2017, By Country 203
Figure 56: Average Revenue Per Pharmaceutical Enterprises, 2017, By Country, USD Million 204
Figure 57: Generic & Branded Sales Proportion By Country (Value), 2017 207
Figure 58: New Drug Approvals, 2017, By Country 208
Figure 59: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 214
Figure 60: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 216
Figure 61: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217
Figure 62: Asia Pacific Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 218
Figure 63: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 224
Figure 64: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 226
Figure 65: China Pharmaceutical Drugs Market, Segmentation By Type, 2017 227
Figure 66: China Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 228
Figure 67: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 234
Figure 68: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 236
Figure 69: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237
Figure 70: India Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 238
Figure 71: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 244
Figure 72: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 246
Figure 73: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247
Figure 74: Japan Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 248
Figure 75: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 250
Figure 76: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 252
Figure 77: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253
Figure 78: Australia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 254
Figure 79: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 260
Figure 80: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 261
Figure 81: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262
Figure 82: Western Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth rates, Segmentation By Type 264
Figure 83: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 268
Figure 84: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 270
Figure 85: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271
Figure 86: UK Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 273
Figure 87: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 275
Figure 88: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 277
Figure 89: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278
Figure 90: Germany Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 280
Figure 91: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 282
Figure 92: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 284
Figure 93: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285
Figure 94: France Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 287
Figure 95: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 289
Figure 96: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 291
Figure 97: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292
Figure 98: Italy Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 293
Figure 99: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 296
Figure 100: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 297
Figure 101: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298
Figure 102: Spain Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 299
Figure 103: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 303
Figure 104: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 305
Figure 105: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306
Figure 106: Eastern Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rate, Segmentation By Type 307
Figure 107: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 310
Figure 108: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 311
Figure 109: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312
Figure 110: Russia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 314
Figure 111: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 319
Figure 112: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 321
Figure 113: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322
Figure 114: North America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 324
Figure 115: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 329
Figure 116: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 330
Figure 117: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331
Figure 118: USA Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 333
Figure 119: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 338
Figure 120: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 340
Figure 121: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341
Figure 122: South America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 343
Figure 123: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 345
Figure 124: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 346
Figure 125: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347
Figure 126: Brazil Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 348
Figure 127: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 352
Figure 128: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 354
Figure 129: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355
Figure 130: Middle East Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 357
Figure 131: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 361
Figure 132: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 363
Figure 133: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364
Figure 134: Africa Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 366
Figure 135: Global Pharmaceutical Drugs Market, Key Competitor Market Shares, 2017, Percentage (%) 368
Figure 136: Novartis AG Financial Performance 371
Figure 137: Sanofi Financial Performance 373
Figure 138: Pfizer Inc. Financial Performance 375
Figure 139: Gilead Sciences Inc. Financial Performance 377
Figure 140: Global Healthcare Market, Historic Market Size, 2013-2017 , USD Billion 384
Figure 141: Global Healthcare Market, Forecast Market Size, 2013-2017 , USD Billion 387
Figure 142: Healthcare Market, 2017, By Region 390
Figure 143: Healthcare Market, 2013-2021, Historic And Forecast Growth Rates, By Region 392
Figure 144: Healthcare Market, 2017, By Country 394
Figure 145: Healthcare Market, 2013-2021, Historic And Forecast Growth Rates, By Country 396
Figure 146: Healthcare Market Segmentation, By Region, 2017 398
Figure 147: Healthcare Market Segmentation, By Country, 2017 399
Figure 148: Global Healthcare Market Size, Percentage Of GDP 401
Figure 149: Global Per Capita Average Healthcare Expenditure 402
Figure 150: Global Healthcare Market Size, Percentage Of GDP, By Country 403
Figure 151: Per Capita Average Healthcare Expenditure, By Country 404
List of Table
Table 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 31
Table 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 35
Table 3: Pharmaceutical Drugs Market, 2017, Split By Region 43
Table 4: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45
Table 5: Pharmaceutical Drugs Market, 2017, Split By Country 47
Table 6: Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 49
Table 7: Global Pharmaceutical Drugs Market, Split By Segments, 2017, USD Billion 52
Table 8: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segment 55
Table 9: Global Musculoskeletal Disorders Drugs Market, 2017, By Subsegment 61
Table 10: Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Subsegment 62
Table 11: Global Musculoskeletal Drugs Market, Key Competitor Market Shares And Revenues, 2017, 64
Table 12: Global Cardiovascular Drugs Market, 2017, Segmentation By Subsegment 72
Table 13: Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 73
Table 14: Global Cardiovascular Market, Competitor Market Shares and Revenues, 2017 75
Table 15: Global Oncology Drugs Market, 2017, Segmentation By Subegment 82
Table 16: Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 85
Table 17: Global Oncology Drugs Market, Competitor Market Shares and Revenues, 2017 87
Table 18: Global Anti-Infective Drugs Market, 2017, Segmentation, By Subsegment 95
Table 19: Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 97
Table 20: Global Anti-Infective Drugs Market, Competitor Market Shares and Revenues, 2017 99
Table 21: Global Metabolic Disorders Drugs Market, 2017, Segmentation By Segment 107
Table 22: Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 108
Table 23: Global Metabolic Disorder Drugs Market, Competitor Market Shares and Revenues, 2017 110
Table 24: Global Central Nervous System Drugs Market, 2017, Segmentation By Segment 117
Table 25: Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 119
Table 26: Global Central Nervous System Drugs Market, Competitor Market Shares and Revenues, 2017 121
Table 27: Global Genito-Urinary Drugs Market, 2017, Segmentation By Subsegment 129
Table 28: Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 131
Table 29: Global Genito-Urinary Drugs Market, Competitor Market Shares And Reveneues, 2017 133
Table 30: Global Respiratory Diseases Market, 2017, Segmentation By Subsegment 142
Table 31: Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 143
Table 32: Global Respiratory Diseases Drugs Market, Competitor Market Shares And Revenues, 2017 144
Table 33: Global Gastrointestinal Drugs Market, 2017, Segmentation By Subsegment 151
Table 34: Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 153
Table 35: Global Gastrointestinal Drugs Market, Competitor Market Shares And Revenues, 2017 155
Table 36: Global Hematology Drugs Market, 2017, Segmentation By Subsegment 163
Table 37: Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 164
Table 38: Global Hematology Drugs Market, Competitor Market Shares And Revenues, 2017 165
Table 39: Global Dermatology Drugs Market, Competitor Market Shares And Revenues, 2017 173
Table 40: Global Ophthalmology Drugs Market, 2017, Segmentation, By Subsegment 181
Table 41: Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 183
Table 42: Global Ophthalmology Drugs Market, Competitor Market Shares And Revenues, 2017 184
Table 43: Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 189
Table 44: Per Capita Average Pharmaceutical Drugs Expenditure, Global 190
Table 45: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country, 2017 191
Table 46: Per Capita Average Pharmaceutical Drugs Expenditure, By Country, 2017 192
Table 47: Number Of General Practitioners 2017, By Country, Thousands 194
Table 48: Average Revenue Per General Practitioner, 2017, By Country, USD Thousands 196
Table 49: l Number Of Pharmacies Per 100,000 Population, 2017, By Country 197
Table 50: Number Of Pharmacists, 2017, By Country, Thousands 198
Table 51: Average Revenue Per Pharmacist, 2017, By Country, USD Thousands 199
Table 52: Number Of Employees In Pharmaceutical Industry (in Thousands), 2017, By Country 200
Table 53: Average Revenue Per Pharmaceutical Employee, 2017, By Country, USD Thousands 202
Table 54: Number Of Pharmaceutical Enterprises, 2017, By Country 203
Table 55: Average Revenue Per Pharmaceutical Enterprises, 2017, By Country, USD Million 204
Table 56: Generic & Branded Sales Proportion By Country (Value), 2017 207
Table 57: New Drug Approvals, 2017, By Country 208
Table 58: Asia Pacific Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 215
Table 59: Asia Pacific Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 216
Table 60: Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type, 2017 217
Table 61: Asia Pacific Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 219
Table 62: China Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 224
Table 63: China Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 226
Table 64: China Pharmaceutical Drugs Market, Segmentation, By Type, 2017 227
Table 65: China Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 229
Table 66: India Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 234
Table 67: India Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 236
Table 68: India Pharmaceutical Drugs Market, Segmentation By Type, 2017 237
Table 69: India Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 239
Table 70: Japan Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 244
Table 71: Japan Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 246
Table 72: Japan Pharmaceutical Drugs Market, Segmentation By Type, 2017 247
Table 73: Japan Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth rates, Segmentation By Type 249
Table 74: Australia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 250
Table 75: Australia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 252
Table 76: Australia Pharmaceutical Drugs Market, Segmentation By Type, 2017 253
Table 77: Australia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 255
Table 78: Western Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 260
Table 79: Western Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 261
Table 80: Western Europe Pharmaceutical Drugs Market, Segmentation By Type 262
Table 81: Western Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 264
Table 82: UK Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 268
Table 83: UK Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 270
Table 84: UK Pharmaceutical Drugs Market, Segmentation By Type, 2017 271
Table 85: UK Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 273
Table 86: Germany Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 276
Table 87: Germany Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 277
Table 88: Germany Pharmaceutical Drugs Market, Segmentation By Type, 2017 278
Table 89: Germany Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 280
Table 90: France Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 282
Table 91: France Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 284
Table 92: France Pharmaceutical Drugs Market, Segmentation By Type, 2017 285
Table 93: France Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 287
Table 94: Italy Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 290
Table 95: Italy Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 291
Table 96: Italy Pharmaceutical Drugs Market, Segmentation By Type, 2017 292
Table 97: Italy Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 294
Table 98: Spain Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 296
Table 99: Spain Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 297
Table 100: Spain Pharmaceutical Drugs Market, Segmentation By Type, 2017 298
Table 101: Spain Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 300
Table 102: Eastern Europe Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 303
Table 103: Eastern Europe Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 305
Table 104: Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, 2017 306
Table 105: Eastern Europe Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rate, Segmentation By Type 308
Table 106: Russia Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 310
Table 107: Russia Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 311
Table 108: Russia Pharmaceutical Drugs Market, Segmentation By Type, 2017 312
Table 109: Russia Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 314
Table 110: North America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 319
Table 111: North America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 321
Table 112: North America Pharmaceutical Drugs Market, Segmentation By Type, 2017 322
Table 113: North America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 324
Table 114: USA Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 329
Table 115: USA Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 330
Table 116: USA Pharmaceutical Drugs Market, Segmentation By Type, 2017 331
Table 117: USA Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 333
Table 118: South America Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 339
Table 119: South America Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 340
Table 120: South America Pharmaceutical Drugs Market, Segmentation By Type, 2017 341
Table 121: South America Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 343
Table 122: Brazil Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 345
Table 123: Brazil Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 346
Table 124: Brazil Pharmaceutical Drugs Market, Segmentation By Type, 2017 347
Table 125: Brazil Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 349
Table 126: Middle East Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 352
Table 127: Middle East Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 354
Table 128: Middle East Pharmaceutical Drugs Market, Segmentation By Type, 2017 355
Table 129: Middle East Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 357
Table 130: Africa Pharmaceutical Drugs Market, Historic Market Size, 2013-2017 , USD Billion 361
Table 131: Africa Pharmaceutical Drugs Market, Forecast Market Size, 2017-2021 , USD Billion 363
Table 132: Africa Pharmaceutical Drugs Market, Segmentation By Type, 2017 364
Table 133: Africa Pharmaceutical Drugs Market, 2013-2021, Historic And Forecast Growth Rates, Segmentation By Type 366
Table 134: Global Pharmaceutical Drugs Market, Competitor Market Shares And Revenues, 2017 368
Table 135: Novartis AG Financial Performance 371
Table 136: Sanofi S.A Financial Performance 373
Table 137: Pfizer Financial Performance 375
Table 138: Gilead Sciences Financial Performance 377
Table 139: Global Healthcare Market, Historic Market Size, 2013-2017 , USD Billion 384
Table 140: Global Healthcare Market, Forecast Market Size, 2013-2017 , USD Billion 387
Table 141: Healthcare Market, 2017, Split By Region 391
Table 142: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 392
Table 143: Healthcare Market, 2017, Split By Country 394
Table 144: Healthcare Market, 2013-2017, Historic And Forecast Growth Rate, Split By Country 396
Table 145: Healthcare Market Segmentation, By Region, 2017 398
Table 146: Healthcare Market Segmentation, By Country, 2017 399
Table 147: Healthcare Market Size, Percentage Of GDP, Global 401
Table 148: Global Per Capita Average Healthcare Expenditure 402
Table 149: Healthcare Market Size, Percentage Of GDP, By Country 403
Table 150: Per Capita Average Healthcare Expenditure, By Country 404
Table 151: Global Pharmaceutical Drugs Market, Market Data Sources 409
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.